Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.
Shiono S, Yanagawa N. Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma. Interact Cardiovasc Thorac Surg. 2016;23:567–72.
Kadota K, Nitadori JI, Sima CS, Ujiie H, Rizk NP, Jones DR, et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas. J Thorac Oncol. 2015;10:806–14.
CAS PubMed PubMed Central Google Scholar
Dai C, Xie H, Su H, She Y, Zhu E, Fan Z, et al. Tumor spread through air spaces affects the recurrence and overall survival in patients with lung adenocarcinoma >2 to 3 cm. J Thorac Oncol. 2017;12:1052–60.
Toyokawa G, Yamada Y, Tagawa T, Kozuma Y, Matsubara T, Haratake N, et al. Significance of spread through air spaces in resected pathological stage I lung adenocarcinoma. Ann Thorac Surg. 2018;105:1655–63.
Eguchi T, Kameda K, Lu S, Bott MJ, Tan KS, Montecalvo J, et al. Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score-matched analysis. J Thorac Oncol. 2019;14:87–98.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607–17.
Tane S, Okami J, Maniwa Y, Shintani Y, Ito H, Ohtsuka T, et al. Clinical outcomes of left upper segmentectomy vs. lobectomy for early non-small-cell lung cancer: a nationwide database study in Japan. Surg Today. 2024;54:1162–72.
PubMed PubMed Central Google Scholar
Li H, Li L, Liu Y, Deng Y, Zhu Y, Huang L, et al. Predictive value of CT and (18)F-FDG PET/CT features on spread through air space in lung adenocarcinoma. BMC Cancer. 2024;24:434.
PubMed PubMed Central Google Scholar
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.
Lee MA, Kang J, Lee HY, Kim W, Shon I, Hwang NY, et al. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: incidence, prognostic impact, and prediction based on clinicoradiologic factors. Thorac Cancer. 2020;11:3145–54.
CAS PubMed PubMed Central Google Scholar
Uruga H, Fujii T, Fujimori S, Kohno T, Kishi K. Semiquantitative assessment of tumor spread through air spaces (STAS) in early-stage lung adenocarcinomas. J Thorac Oncol. 2017;12:1046–51.
Shiono S, Endo M, Suzuki K, Yarimizu K, Hayasaka K, Yanagawa N. Spread through air spaces is a prognostic factor in sublobar resection of non-small cell lung cancer. Ann Thorac Surg. 2018;106:354–60.
Yang L, Yang Y, Ma P, Zheng B, Liu W, Zhang Z, et al. Spread through air spaces predicts a worse survival in patients with stage I adenocarcinomas >2 cm after radical lobectomy. J Thorac Dis. 2018;10:5308–17.
PubMed PubMed Central Google Scholar
Kagimoto A, Tsutani Y, Kushitani K, Kai Y, Kambara T, Miyata Y, et al. Segmentectomy vs lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces. Ann Thorac Surg. 2021;112:935–43.
Shimomura M, Miyagawa-Hayashino A, Omatsu I, Asai Y, Ishihara S, Okada S, et al. Spread through air spaces is a powerful prognostic predictor in patients with completely resected pathological stage I lung adenocarcinoma. Lung Cancer. 2022;174:165–71.
Lv Y, Li S, Liu Z, Ren Z, Zhao J, Tao G, et al. Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces. Lung Cancer. 2023;177:51–8.
Shiono S, Endo M, Suzuki K, Yanagawa N. Spread through air spaces affects survival and recurrence of patients with clinical stage IA non-small cell lung cancer after wedge resection. J Thorac Dis. 2020;12:2247–60.
PubMed PubMed Central Google Scholar
Zhang Z, Liu Z, Feng H, Xiao F, Shao W, Liang C, et al. Predictive value of radiological features on spread through air space in stage cIA lung adenocarcinoma. J Thorac Dis. 2020;12:6494–504.
PubMed PubMed Central Google Scholar
Yamamoto M, Tamura M, Miyazaki R, Okada H, Wada N, Toi M, et al. Mean computed tomography value to predict spread through air spaces in clinical N0 lung adenocarcinoma. J Cardiothorac Surg. 2024;19:260.
PubMed PubMed Central Google Scholar
Imamura Y, Azuma K, Kurata S, Hattori S, Sasada T, Kinoshita T, et al. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy. Lung Cancer. 2011;71:49–54.
Nakamura H, Saji H, Shinmyo T, Tagaya R, Kurimoto N, Koizumi H, et al. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Lung Cancer. 2015;87:28–33.
Kawabata K, Takahashi T, Nishida T, Kurokawa Y, Yamamoto K, Saito T, et al. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors. Surgery Today. 2025;55: Epub ahead of print.
Nishimori M, Iwasa H, Miyatake K, Nitta N, Nakaji K, Matsumoto T, et al. 18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma. Ann Nucl Med. 2022;36:897–903.
Wang Y, Lyu D, Cheng C, Zhou T, Tu W, Xiao Y, et al. Preoperative nomogram for predicting spread through air spaces in clinical-stage IA non-small cell lung cancer using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. J Cancer Res Clin Oncol. 2024;150:185.
CAS PubMed PubMed Central Google Scholar
Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989;57:327–34.
Zhang Z, Zhao Y, Ma YJ, Chen CQ, Li ZY, Wang YK, et al. Prediction of STAS in lung adenocarcinoma with nodules </= 2 cm using machine learning: a multicenter retrospective study. BMC Cancer. 2025;25:417.
CAS PubMed PubMed Central Google Scholar
Eguchi T, Matsuoka S, Iwaya M, Kobayashi S, Seshimoto M, Mishima S, et al. Improving intraoperative diagnosis of spread through air spaces: a cryo-embedding-medium inflation method for frozen section analysis. JTCVS Tech. 2024;25:170–6.
Comments (0)